Confronting a bird flu outbreak in nature presents unique challenges, as infected animals leave a landscape contaminated, Pa.

(Alliance News) - hVIVO PLC on Monday said it has signed a contract with Inhalon Biopharma Inc to test its antiviral candidate to treat respiratory syncytial virus. The London-based contract research ...

Nirsevimab is protective against RSV infections and coinfections, which suggests there is no replacement of RSV with other viruses post-nirsevimab administration.

US-based Inhalon Biopharma is set to launch a trial of its at-home nebulised treatment for respiratory syncytial virus (RSV) ...

UK contract research organization hVIVO (AIM: HVO) is gearing up to test an inhaled antiviral candidate, IN-002, for ...

Inhalon Biopharma, Inc. (Inhalon), a clinical-stage company advancing a first-in-class inhaled antibody platform for treating acute respiratory infections (ARI), today announced the completion of ...

It’s what’s being called a “Quad-demic,” with cases on the rise for COVID-19, Respiratory syncytial virus (RSV), Influenza, ...

The UKHSA has noted that COVID symptoms have evolved over time. Many individuals now exhibit cold-like symptoms, but others ...

A data point is marked as “insufficient data” if wastewater samples test negative for a virus (because levels are too low to ...

The main treatment for most respiratory illnesses is supportive care, with over-the-counter remedies, Myers said, noting antibiotics are not effective. Care at-home can include: rest, adequate fluid ...

The UK Health Security Agency (UKHSA) issued the urgent alert on Thursday saying illnesses like Norovirus and the flu were on ...

The main signs of HMPV, a highly infectious virus that has apparently swept over regions of northern China in recent weeks, ...